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US28 is a chemokine receptor encoded by the human
cytomegalovirus (hCMV) and seems to be crucial for viral
propagation. It is a constitutively active receptor. For
instance it was shown that US28 signals via Gq/PLC and
activates the transcription factors nuclear factor κB
(NFκB), cyclic AMP response element binding protein
(CREB) and nuclear factor of activated T-cells (NFAT).
Hence, the receptor may play a key role in the early repro-
gramming of the host cells. Interestingly, US28 is consti-
tutively phosphorylated and endocytosed. It has also been
suggested that, during viral propagation, US28 is inte-
grated into the viral envelope in the lysosomes of host
cells. A candidate protein for sorting many G protein-cou-
pled receptors to lysosomes is the G protein-coupled
receptor-associated protein-1 (GASP-1). Here, we show
that GASP-1 and the C-terminal part of GASP-1 (cGASP-
1) interact with the far C-terminal end of US28 in vitro. We
assessed this by using in vitro translated, [35S]methionine-
radiolabelled GASP-1 and cGASP-1 and several different
US28 C-terminal mutations and truncations in a GST
pull-down assay.
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